AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)
AAPL 186.61 +0.12 (+0.06%)MSFT 126.9 +0.03 (+0.02%)FB 184.76 +0.03 (+0.02%)ZNGA 6.17 0 (+0.08%)NVDA 155.05 -0.2 (-0.13%)WBA 52.73 +0.06 (+0.11%)GOOG 1148.79 -1.09 (-0.09%)PIH 5.7 -0.12 (-2.06%)

Financial Summary APEN Quote Apollo Endo

Apollo Endosurgery Inc. Quote

Apollo Endosurg (APEN)

3.53 -0.18 Healthcare
Stock Performance rating :
Recommendation :
Strong Sell
Score :
C-
Symbol APEN
Price 3.53
Beta 0.74
Vol Avg 28.13 K
Mkt cap 72.97 M
Shares Not Available
Last Div Not Available
Div Yield Not Available
DCF Unlevered 0.00
DCF Levered 0.00
ROE -181.82% Strong Sell
ROA -166.67% Strong Sell
Operating Margin -550.00% Strong Sell
Debt/Equity 9.09% Neutral
P/E 0.00 Neutral
P/B 0.00 Neutral
All | Income Statement | Balance Sheet | Cash Flow | Retained Earnings | PPE Schedule | Intangible and Goodwill Schedule
Income Statement
Year 20142015201620172018
Revenue 8 5 2 0 0
COGS 0 0 0 25 25
GrossProfit 8 5 2 40 40
Depreciation (included in COGS) 0 0 0 0 0
StockBasedCompe (included in COGS) 1 1 1 0 1
ResearchAndDeve 11 18 9 8 8
SalesGeneralAnd 4 5 4 45 47
OperatingIncome -8 -18 -11 -21 -22
InterestExpense 0 0 0 0 0
OtherIncome 1 1 1 -20 -5
IncomeBeforeTax -7 -17 -10 -41 -27
ProvisionForInc 0 0 0 0 0
NetIncome -7 -17 -10 -41 -27
Balance Sheet
Year 20142015201620172018
CashAndCashEqui 12 17 9 19 31
ShortTermInvest 0 0 0 0 0
Cash 12 17 9 0 0
AccountReceivab 1 1 0 0 0
Inventories 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
OtherCurrentAss 0 0 0 0 0
TotalCurrentAss 13 18 9 44 58
PPE 1 1 1 11 14
AccumulatedDepr 0 -1 -1 -4 -7
NetPPE 0 0 0 7 7
EquityAndOtherI 0 0 0 0 0
Goodwill 0 0 0 7 7
IntangibleAsset 2 2 2 43 36
OtherLTAssets 0 0 0 1 1
TotalNonCurrent 2 3 2 59 51
TotalAssets 16 21 12 102 109
ShortTermDebt 0 0 0 0 0
AccountsPayable 2 3 0 0 0
TaxesPayable 0 0 0 0 1
AccruedLiabilit 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherCurrentLia 1 1 1 12 4
TotalCurrentLia 4 4 1 20 26
Debt 0 0 0 0 0
DeferredTaxesLi 0 0 0 0 0
DeferredRevenue 0 0 0 0 0
OtherLTLiabilit 2 1 0 0 0
TotalNonCurrent 2 1 0 39 33
TotalLiabilitie 6 5 1 60 59
CommonStock 0 0 0 0 0
AdditionalPaidI 59 82 87 191 225
RetainedEarning -49 -66 -76 -150 -177
AccumulatedOthe 0 0 0 1 2
TotalStockholde 10 16 11 42 50
TotalLiabilitie 16 21 12 102 109
Cash Flow Statement
Year 20142015201620172018
NetIncome -7 -17 -10 -41 -27
Depreciation 0 0 0 0 0
DeferredIncomeT 0 0 0 0 0
StockBasedCompe 1 1 1 0 1
AccountsReceiva -1 1 1 0 -1
InventoryCS 0 0 0 -3 -3
AccountsPayable 0 0 0 0 0
OtherWorkingCap -6 1 -3 4 5
OtherNonCashIte -1 0 -1 19 2
NetCashProvided -13 -15 -12 -13 -13
InvestmentsInPP 0 0 0 -1 -2
AcquisitionsNet 0 0 0 0 0
PurchasesOfInve 0 0 0 0 0
SalesMaturities 0 0 0 0 0
PurchasesOfInta 0 0 0 -1 -1
OtherInvestingA 0 0 0 0 0
NetCashUsedForI 0 -1 0 -2 -2
DebtIssued 0 0 0 0 0
DebtRepayment 0 0 0 -11 -7
CommonStockIssu 0 0 0 29 34
CommonStockRepu 0 0 0 0 0
DividendPaid 0 0 0 0 0
OtherFinancingA 1 21 4 -5 0
NetCashProvided 1 21 4 13 27
NetChangeInCash -13 5 -8 -3 11
CashAtBeginning 25 12 17 23 20
CashAtEndOfPeri 12 17 9 20 31
Retained Earnings
Year 20142015201620172018
RetainedEarning ----49-66
NetIncome ---7-17-10
StockDividend --563420
DividendPaid -----
RetainedEarning ---49-66-76
Property Plant and Equipment Schedule
Year 20142015201620172018
NetPPE -----
DeprAnnual 0---1-
CapitalExpendit 00010
NetPPE -----
Intangible and Goodwill Schedule
Year 20142015201620172018
intAndGW 0--22
Amortization 0--1-
NewPurchases 0-2-1-
intAndGW --222
Company Profile

CEO

Sector

Healthcare

Industry

Medical Devices

Exchange

NASDAQ Global Market

Description

Apollo Endosurgery Inc is a developer of medical devices in the United States. The company's major focus area is obesity and gastrointestinal diseases.